Memorial Sloan Kettering Cancer Center


Hospital

Location:
New York, NY, United States (USA)


Publications in cooperation with FAU scientists


Go to first page Go to previous page 1 of 3 Go to next page Go to last page
Heinzerling, L., Ascierto, P.A., Dummer, R., Gogas, H., Grob, J.-J., Lebbe, C.,... Hauschild, A. (2019). Adverse events 2.0-Let us get SERIOs New reporting for adverse event outcomes needed in the era of immunooncology. European journal of cancer, 112, 29-31. https://dx.doi.org/10.1016/j.ejca.2019.01.015
Turner, N.C., Telli, M.L., Rugo, H.S., Mailliez, A., Ettl, J., Grischke, E.-M.,... Robson, M.E. (2019). A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). Clinical Cancer Research, 25(9), 2717-2724. https://dx.doi.org/10.1158/1078-0432.CCR-18-1891
Buckley, M.A., Woods, N.T., Tyrer, J.P., Mendoza-Fandino, G., Lawrenson, K., Hazelett, D.J.,... Freedman, M.L. (2019). Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-17-3864
Deniset, J.F., Belke, D., Lee, W.Y., Jorch, S.K., Deppermann, C., Hassanabad, A.F.,... Kubes, P. (2019). Gata6+ Pericardial Cavity Macrophages Relocate to the Injured Heart and Prevent Cardiac Fibrosis. Immunity. https://dx.doi.org/10.1016/j.immuni.2019.06.010
Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-18-2726
Awadalla, M., Golden, D.L.A., Mahmood, S.S., Alvi, R.M., Mercaldo, N.D., Hassan, M.Z.O.,... Neilan, T.G. (2019). Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer, 7. https://dx.doi.org/10.1186/s40425-019-0535-y
Baltzer, P.A., Kapetas, P., Sodano, C., Dietzel, M., Pinker, K., Helbich, T.H., & Clauser, P. (2019). Kontrastmittelfreie Mamma-MRT: Vorteile und potenzielle Nachteile. Radiologe. https://dx.doi.org/10.1007/s00117-019-0524-7
Engle, D.D., Tiriac, H., Rivera, K.D., Pommier, A., Whalen, S., Oni, T.E.,... Tuveson, D.A. (2019). The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science, 364(6446), 1156-1162. https://dx.doi.org/10.1126/science.aaw3145
Capdevila, J., Bodei, L., Davies, P., Gorbounova, V., Jensen, R.T., Knigge, U.P.,... Wiedenmann, B. (2019). Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms. Neuroendocrinology, 108(1), 18-25. https://dx.doi.org/10.1159/000493319
Yao, J.C., Strosberg, J., Fazio, N., Pavel, M.E., Ruszniewski, P., Bergsland, E.,... Singh, S. (2018). Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx). In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.
Capper, D., Jones, D.T.W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D.,... Pfister, S.M. (2018). DNA methylation-based classification of central nervous system tumours. Nature, 555(7697), 469-474. https://dx.doi.org/10.1038/nature26000
Martinez-Barricarte, R., Markle, J.G., Ma, C.S., Deenick, E.K., Ramirez-Alejo, N., Mele, F.,... Casanova, J.-L. (2018). Human IFN-gamma immunity to mycobacteria is governed by both IL-12 and IL-23. Science immunology, 3(30). https://dx.doi.org/10.1126/sciimmunol.aau6759
O'Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J.,... Thompson, D.J. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications, 9(1). https://dx.doi.org/10.1038/s41467-018-05427-7
Galon, J., Mlecnik, B., Hermitte, F., Marliot, F., Bifulco, C., Lugli, A.,... Pages, F. (2018). MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies. In ANNALS OF ONCOLOGY. Geneva, CH: OXFORD: OXFORD UNIV PRESS.
Kelemen, L.E., Earp, M., Fridley, B.L., Chenevix-Trench, G., Fasching, P., Beckmann, M.,... Berchuck, A. (2018). rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences, 19(9). https://dx.doi.org/10.3390/ijms19092473
Boisson-Dupuis, S., Ramirez-Alejo, N., Li, Z., Patin, E., Rao, G., Kerner, G.,... Casanova, J.-L. (2018). Tuberculosis and impaired IL-23-dependent IFN-gamma immunity in humans homozygous for a common TYK2 missense variant. Science immunology, 3(30). https://dx.doi.org/10.1126/sciimmunol.aau8714
Earp, M., Tyrer, J.P., Winham, S.J., Lin, H.-Y., Chornokur, G., Dennis, J.,... Phelan, C.M. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS ONE, 13(7). https://dx.doi.org/10.1371/journal.pone.0197561
Haycock, P.C., Burgess, S., Nounu, A., Zheng, J., Okoli, G.N., Bowden, J.,... Smith, G.D. (2017). Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncology, 3(5), 636-651. https://dx.doi.org/10.1001/jamaoncol.2016.5945
Dietzel, M., Kaiser, C., Pinker, K., Wenkel, E., Hammon, M., Uder, M.,... Baltzer, P. (2017). Automated Semi-Quantitative Analysis of Breast MRI: Potential Imaging Biomarker for the Prediction of Tissue Response to Neoadjuvant Chemotherapy. Breast Care, 12(4), 231-236. https://dx.doi.org/10.1159/000480226
Kar, S.P., Adler, E., Tyrer, J., Hazelett, D., Anton-Culver, H., Bandera, E.V.,... Lawrenson, K. (2017). Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer, 116(4), 524-535. https://dx.doi.org/10.1038/bjc.2016.426

Last updated on 2016-29-04 at 08:06